
Suraksha Diagnostic Limited has announced the resignation of its Chief Financial Officer (CFO) and Key Managerial Personnel (KMP), Mr. Amit Saraf. The resignation letter, received on January 16, 2025, cited personal reasons for his decision to step down. Mr. Saraf’s last working day with the company will be on or before February 15, 2025.
The company, in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, has informed the stock exchanges about the development. Further details regarding the next steps and appointment of a successor are awaited.
Suraksha Diagnostic Ltd’s IPO shares made their stock market debut today, December 6, 2024, listing at a discount compared to the issue price. The shares were listed at ₹437 on the BSE and ₹438 on the NSE, compared to the issue price of ₹441. This resulted in a per-lot loss of ₹136 on the BSE and ₹102 on the NSE for retail investors.
IPO Details:
- Issue Price: ₹441
- Retail Lot Size: 34 shares
- Listing Price:
- BSE: ₹437
- NSE: ₹438
- Loss Per Lot:
- BSE: ₹136
- NSE: ₹102
Suraksha Diagnostic Ltd had launched its IPO between November 29 and December 3, priced in the range of ₹420–₹441 per share. The IPO received a moderate response, being subscribed 1.27 times, with 1.70 crore shares bid against 1.34 crore shares on offer.
The issue, an Offer for Sale (OFS) of 1.92 crore equity shares, allowed the company to raise ₹846.25 crore at the upper end of the price band.
Key Dates and Listing Details:
- IPO Opening Date: November 29, 2024
- IPO Closing Date: December 3, 2024
- IPO Allotment Finalization: December 4, 2024
- Listing Date: December 6, 2024
Disclaimer: This article is for informational purposes only and should not be considered financial or investment advice.